Harvard Bioscience Stock Price on January 31, 2025

HBIO Stock  USD 0.85  0.04  4.49%   
Below is the normalized historical share price chart for Harvard Bioscience extending back to December 07, 2000. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Harvard Bioscience stands at 0.85, as last reported on the 28th of February, with the highest price reaching 0.95 and the lowest price hitting 0.85 during the day.
IPO Date
7th of December 2000
200 Day MA
2.5235
50 Day MA
1.7594
Beta
1.252
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Harvard Stock, it is important to understand the factors that can impact its price. Harvard Bioscience holds Efficiency (Sharpe) Ratio of -0.36, which attests that the entity had a -0.36 % return per unit of risk over the last 3 months. Harvard Bioscience exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Harvard Bioscience's Market Risk Adjusted Performance of (0.63), standard deviation of 4.06, and Risk Adjusted Performance of (0.23) to validate the risk estimate we provide.
  
As of the 28th of February 2025, Total Stockholder Equity is likely to drop to about 82.7 M. In addition to that, Common Stock Shares Outstanding is likely to drop to about 33.1 M. At this time, Harvard Bioscience's Price Book Value Ratio is very stable compared to the past year. As of the 28th of February 2025, Price Earnings To Growth Ratio is likely to grow to 0.97, while Price To Sales Ratio is likely to drop 1.72. Harvard Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.3595

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsHBIO

Estimated Market Risk

 4.2
  actual daily
37
63% of assets are more volatile

Expected Return

 -1.51
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.36
  actual daily
0
Most of other assets perform better
Based on monthly moving average Harvard Bioscience is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Harvard Bioscience by adding Harvard Bioscience to a well-diversified portfolio.
Price Book
0.5931
Enterprise Value Ebitda
179.2557
Price Sales
0.3793
Shares Float
35 M
Wall Street Target Price
6.25

Related Headline

InfuSystems Holdings Headline on 31st of January 2025

Filed transaction by InfuSystems Holdings Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Harvard Bioscience Valuation on January 31, 2025

It is possible to determine the worth of Harvard Bioscience on a given historical date. On January 31, 2025 Harvard was worth 1.8 at the beginning of the trading date compared to the closed value of 1.71. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Harvard Bioscience stock. Still, in general, we apply an absolute valuation method to find Harvard Bioscience's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Harvard Bioscience where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Harvard Bioscience's related companies.
 Open High Low Close Volume
  1.76    1.83    1.71    1.77    171,787  
01/31/2025
  1.80    1.80    1.71    1.71    144,043  
  1.70    1.70    1.63    1.65    295,368  
Backtest Harvard Bioscience  |  Harvard Bioscience History  |  Harvard Bioscience Valuation PreviousNext  
Open Value
1.8
1.71
Closing Value
14.39
Upside

Harvard Bioscience Trading Date Momentum on January 31, 2025

On February 03 2025 Harvard Bioscience was traded for  1.65  at the closing time. The top price for the day was 1.70  and the lowest listed price was  1.63 . The trading volume for the day was 295.4 K. The trading history from February 3, 2025 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 3.51% . The trading delta at closing time against the current closing price is 15.79% .
JavaScript chart by amCharts 3.21.1501/31/2025Jan 21Jan 24Jan 27Jan 30FebFeb 05Feb 081.41.51.61.71.81.9

Harvard Bioscience Fundamentals Correlations and Trends

By evaluating Harvard Bioscience's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Harvard Bioscience's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Harvard financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Harvard Bioscience Stock history

Harvard Bioscience investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Harvard is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Harvard Bioscience will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Harvard Bioscience stock prices may prove useful in developing a viable investing in Harvard Bioscience
Last ReportedProjected for Next Year
Common Stock Shares Outstanding48.8 M33.1 M
Net Loss-8.6 M-8.1 M

Harvard Bioscience Quarterly Net Working Capital

24.04 Million

100%

Harvard Bioscience Stock Technical Analysis

Harvard Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Harvard Bioscience technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Harvard Bioscience trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Harvard Bioscience Period Price Range

Low
February 28, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Harvard Bioscience cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Harvard Bioscience February 28, 2025 Market Strength

Market strength indicators help investors to evaluate how Harvard Bioscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Harvard Bioscience shares will generate the highest return on investment. By undertsting and applying Harvard Bioscience stock market strength indicators, traders can identify Harvard Bioscience entry and exit signals to maximize returns

Harvard Bioscience Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Harvard Bioscience's price direction in advance. Along with the technical and fundamental analysis of Harvard Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Harvard to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Harvard Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Harvard Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Harvard Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Harvard Bioscience Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harvard Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Harvard Stock, please use our How to Invest in Harvard Bioscience guide.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harvard Bioscience. If investors know Harvard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harvard Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.80)
Earnings Share
(0.33)
Revenue Per Share
2.258
Quarterly Revenue Growth
(0.13)
Return On Assets
(0.02)
The market value of Harvard Bioscience is measured differently than its book value, which is the value of Harvard that is recorded on the company's balance sheet. Investors also form their own opinion of Harvard Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Harvard Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harvard Bioscience's market value can be influenced by many factors that don't directly affect Harvard Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harvard Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harvard Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harvard Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.